PHAT

13.73

1.33% 0.18

Vorhandelsmarkt: 13.25 -0.48 -3.50%

Phathom Pharmaceuticals Inc (PHAT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$13.55

Offen:

$13.51

24-Stunden-Volumen:

1.21M

Relative Volume:

1.03

Marktkapitalisierung:

$974.06M

Einnahmen:

$114.04M

Nettoeinkommen (Verlust:

$-330.15M

KGV:

-2.9027

EPS:

-4.73

Netto-Cashflow:

$-274.85M

1W Leistung:

-0.58%

1M Leistung:

+12.45%

6M Leistung:

+397.46%

1J Leistung:

-24.85%

1-Tages-Spanne:

$13.17

$14.09

1-Wochen-Bereich:

$13.00

$16.08

52-Wochen-Spanne:

$2.21

$19.50

Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile

Firmenname

Phathom Pharmaceuticals Inc

Sektor

Healthcare (1136)

Branche

Biotechnology (633)

Telefon

(877) 742-8466

Adresse

100 CAMPUS DRIVE,, FLORHAM PARK, NJ

Mitarbeiter

427

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

PHAT's Discussions on Twitter

Vergleichen Sie PHAT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PHAT Phathom Pharmaceuticals Inc	13.73	963.93M	114.04M	-330.15M	-274.85M	-4.73
VRTX Vertex Pharmaceuticals Inc	426.00	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.25	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.07	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	826.28	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.23	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-14	Eingeleitet	Cantor Fitzgerald	Overweight
2024-05-03	Eingeleitet	Stifel	Buy
2024-01-05	Bestätigt	Needham	Buy
2023-08-09	Eingeleitet	H.C. Wainwright	Buy
2023-05-11	Hochstufung	Evercore ISI	In-line → Outperform
2023-03-13	Eingeleitet	Craig Hallum	Buy
2022-10-21	Eingeleitet	Jefferies	Buy
2022-05-06	Herabstufung	Evercore ISI	Outperform → In-line
2021-05-12	Hochstufung	Goldman	Sell → Neutral
2021-02-17	Eingeleitet	BMO Capital Markets	Outperform
2021-02-02	Eingeleitet	Guggenheim	Buy
2020-06-26	Herabstufung	Goldman	Neutral → Sell
2019-11-20	Eingeleitet	Evercore ISI	Outperform
2019-11-19	Eingeleitet	Goldman	Neutral
2019-11-19	Eingeleitet	Jefferies	Buy
2019-11-19	Eingeleitet	Needham	Buy

Alle ansehen

Phathom Pharmaceuticals Inc Aktie (PHAT) Neueste Nachrichten

Nov 03, 2025

What margin trends mean for Phathom Pharmaceuticals Inc. stock2025 Institutional Moves & Weekly Top Performers Watchlists - newser.com

Nov 03, 2025

Will Phathom Pharmaceuticals Inc. stock reach all time highs in 2025Trade Volume Report & High Conviction Trade Alerts - newser.com

Nov 03, 2025

How strong is Phathom Pharmaceuticals Inc. stock revenue growth2025 Growth vs Value & Reliable Breakout Forecasts - newser.com

Nov 03, 2025

Phathom Pharmaceuticals (Nasdaq: PHAT) to join 5 investor conferences; 90‑day webcasts - Stock Titan

Nov 03, 2025

Volume spikes in Phathom Pharmaceuticals Inc. stock – what they mean2025 Biggest Moves & Precise Buy Zone Identification - newser.com

Nov 03, 2025

Will Phathom Pharmaceuticals Inc. stock see PE expansionJuly 2025 EndofMonth & Real-Time Volume Triggers - newser.com

Nov 03, 2025

Volatility clustering patterns for Phathom Pharmaceuticals Inc.Earnings Trend Report & Daily Growth Stock Tips - newser.com

Nov 03, 2025

Is Phathom Pharmaceuticals Inc. a candidate for recovery playMarket Performance Report & Daily Stock Momentum Reports - newser.com

Nov 03, 2025

Why Phathom Pharmaceuticals Inc. stock remains a top recommendationProduct Launch & Safe Entry Point Alerts - newser.com

Nov 03, 2025

Is Phathom Pharmaceuticals Inc. stock a buy on dipsInflation Watch & Long Hold Capital Preservation Plans - newser.com

Nov 03, 2025

Can Phathom Pharmaceuticals Inc. stock sustain market leadershipJuly 2025 Big Picture & Real-Time Volume Analysis Alerts - newser.com

Nov 03, 2025

Comparing Phathom Pharmaceuticals Inc. in custom built stock radarsJuly 2025 Weekly Recap & Community Supported Trade Ideas - newser.com

Nov 03, 2025

Can Phathom Pharmaceuticals Inc. recover in the next quarterPortfolio Return Report & Long-Term Safe Investment Ideas - newser.com

Nov 03, 2025

Is Phathom Pharmaceuticals Inc. stock positioned for digital transformation2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com

Nov 03, 2025

Nov 02, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Just Reported And Analysts Have Been Lifting Their Price Targets - Yahoo Finance

Nov 02, 2025

AlphaQuest LLC Buys 30,760 Shares of Phathom Pharmaceuticals, Inc. $PHAT - MarketBeat

Nov 02, 2025

Nov 01, 2025

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Gap UpTime to Buy? - MarketBeat

Nov 01, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 01, 2025

Will Phathom Pharmaceuticals Inc. stock rally after Fed decisions2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - newser.com

Nov 01, 2025

Oct 31, 2025

Price action breakdown for Phathom Pharmaceuticals Inc.Portfolio Update Summary & AI Based Buy and Sell Signals - newser.com

Oct 31, 2025

Phathom Pharmaceuticals’ Q3 Earnings: Strong Growth Amid Challenges - TipRanks

Oct 31, 2025

Phathom Pharmaceuticals (PHAT): Forecasts Call for 75% Annual Earnings Growth as Losses Deepen - Yahoo Finance

Oct 31, 2025

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Up 8.9% on Strong Earnings - MarketBeat

Oct 31, 2025

HC Wainwright & Co. Raises Price Target for PHAT to $26.00 | PHA - GuruFocus

Oct 31, 2025

Phathom Pharmaceuticals stock price target raised to $20 by Guggenheim - Investing.com Australia

Oct 31, 2025

How sentiment analysis helps forecast Phathom Pharmaceuticals Inc.Quarterly Portfolio Report & Accurate Buy Signal Alerts - newser.com

Oct 31, 2025

Phathom Pharmaceuticals Reports Strong Q3 2025 Growth - TipRanks

Oct 31, 2025

Oct 30, 2025

Phathom Pharmaceuticals Q3 2025 Earnings Call Transcript - MarketBeat

Oct 30, 2025